UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Hanmi to start P1 trial about diabetes combination treatment
Hanmi Pharmaceutical has received approval from the Ministry of Food and Dr...
by Lee Han-soo
|
2019-01-09 14:51
라인
Pharma Research Bio to start P1 clinical trials about BTX
Pharma Research Bio said Monday that it has received approval from the Mini...
by Lee Han-soo
|
2019-01-09 14:51
라인
Regulator keeps Kyung Nam Pharm listed with 1-year grace period
The Korean stock market operator decided to keep Kyung Nam Pharm listed on ...
by Lee Hye-seon
|
2019-01-09 14:49
라인
Anti-Alzheimer drink Souvenaid mired in illegal ad controversy -- again
Handok has illegally promoted Souvenaid, a new drink for mild cognitive imp...
by Lee Min-ju
|
2019-01-08 16:10
라인
Handok and Genexine become largest stakeholder of Rezolute
Korean pharmaceuticals Handok and Genexine said they have jointly become th...
by Lee Hye-seon
|
2019-01-08 14:53
라인
GC, CANbridge ink licensing agreement for Hunter Syndrome drug
GC said Tuesday that it has signed an exclusive licensing agreement in the ...
by Lee Han-soo
|
2019-01-08 12:15
라인
Local firms aim to win rights to sell Vemlidy
Korean drugmakers are seeking to acquire preferential rights to market the ...
by Lee Han-soo
|
2019-01-08 12:14
라인
New influenza drug to be tested in phase-3 trial in Korea
The Korean government has approved a phase-3 clinical trial to evaluate the...
by Lee Hye-seon
|
2019-01-07 15:30
라인
China accepts change in Daewoong’s clinical trial application
Daewoong Pharmaceutical said Monday that the China Food and Drug Administra...
by Lee Han-soo
|
2019-01-07 14:59
라인
Yuhan, Gilead to develop drug against nonalcoholic fatty liver
Yuhan Corp. said Monday that it has signed a licensing and cooperation agre...
by Lee Han-soo
|
2019-01-07 14:00
라인
Regulator to nix approval for Lou Gehrig's drug Yoos Neurosolution
The Korean drug regulator is likely to nullify approval for Yoos Neurosolut...
by Lee Hye-seon
|
2019-01-07 12:46
라인
GSK sales manager leaps to death
A GSK Korea sales manager in charge of consumer healthcare division jumped ...
by Lee Han-soo
|
2019-01-04 14:57
라인
Hyundai Pharm files complaint against Pfizer
Hyundai Pharmaceutical has filed an unfair trade practice complaint against...
by Lee Han-soo
|
2019-01-04 14:57
라인
Pfizer gets larger reimbursement for hemophilia treatments
Pfizer Korea said Thursday that the Ministry of Health and Welfare has appr...
by Lee Han-soo
|
2019-01-03 12:25
라인
Lilly Korea adds indications for ‘Cyramza’ and ‘Taltz’
Lilly Korea said Wednesday that Cyramza (ingredient name: Ramucirumab), its...
by Lee Han-soo
|
2019-01-03 10:49
라인
5 pharmaceuticals’ growth strategies for 2019
Five major local drugmakers celebrated the first working day of 2019 on Wed...
by Lee Hye-seon
|
2019-01-02 16:25
라인
Shire gains expanded insurance coverage for hemophilia treatments
Shire Korea said Wednesday that the Ministry of Food and Drug Safety has ap...
by Lee Han-soo
|
2019-01-02 12:05
라인
Tamiflu-phobia spreads after schoolgirl dies taking the drug
Concerns about Tamiflu (Ingredient: oseltamivir)’s side effects are spreadi...
by Park Gi-taek
|
2018-12-26 15:05
라인
Medicine exports increase thanks to brisk shipments to US
Korea’s cumulative export of medicine and medical suppliers (HS code: 3003,...
by Nam Doo-hyun
|
2018-12-24 15:27
라인
Hyundai Pharm to develop combo drug for diabetes + hypertension
Hyundai Pharmaceutical has started to develop a combination treatment, whic...
by Lee Hye-seon
|
2018-12-24 10:56
-
이전
51
52
53
54
55
56
57
58
59
60
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top